Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study.

Brugada syndrome Desfibrilador automático implantable Electrophysiologic study Estudio electrofisiológico Implantable cardioverter-defibrillator Síndrome de Brugada

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 19 01 2021
accepted: 08 07 2021
pubmed: 5 9 2021
medline: 29 6 2022
entrez: 4 9 2021
Statut: ppublish

Résumé

Multiparametric scores have been designed for better risk stratification in Brugada syndrome (BrS). We aimed to validate 3 multiparametric approaches (the Delise score, Sieira score and the Shanghai BrS Score) in a cohort with Brugada syndrome and electrophysiological study (EPS). We included patients diagnosed with BrS and previous EPS between 1998 and 2019 in 23 hospitals. C-statistic analysis and Cox proportional hazard regression models were used. A total of 831 patients were included (mean age, 42.8±13.1; 623 [75%] men; 386 [46.5%] had a type 1 electrocardiogram (ECG) pattern, 677 [81.5%] were asymptomatic, and 319 [38.4%] had an implantable cardioverter-defibrillator). During a follow-up of 10.2±4.7 years, 47 (5.7%) experienced a cardiovascular event. In the global cohort, a type 1 ECG and syncope were predictive of arrhythmic events. All risk scores were significantly associated with events. The discriminatory abilities of the 3 scores were modest (particularly when these scores were evaluated in asymptomatic patients). Evaluation of the Delise and Sieira scores with different numbers of extra stimuli (1 or 2 vs 3) did not substantially improve the event prediction c-index. In BrS, classic risk factors such as ECG pattern and previous syncope predict arrhythmic events. The predictive capabilities of the EPS are affected by the number of extra stimuli required to induce ventricular arrhythmias. Scores combining clinical risk factors with EPS help to identify the populations at highest risk, although their predictive abilities remain modest in the general BrS population and in asymptomatic patients.

Identifiants

pubmed: 34479845
pii: S1885-5857(21)00223-1
doi: 10.1016/j.rec.2021.07.007
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

559-567

Informations de copyright

Copyright © 2021 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Moisés Rodríguez-Mañero (M)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain; Instituto de Investigación Sanitaria (IDIS), Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address: moirmanero@gmail.com.

Aurora Baluja (A)

Servicio de Anestesiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.

Jaime Hernández (J)

Sección de Arritmias, Servicio de Cardiología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Carmen Muñoz (C)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario de Murcia, Murcia, Spain.

David Calvo (D)

Servicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Juan Fernández-Armenta (J)

Servicio de Cardiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.

Amaya García-Fernández (A)

Servicio de Cardiología, Hospital Universitario General de Alicante, Alicante, Spain.

Esther Zorio (E)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario La Fe, Valencia, Spain.

Álvaro Arce-León (Á)

Servicio de Cardiología, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.

Juan Miguel Sánchez-Gómez (JM)

Servicio de Cardiología, Hospital Universitario Clínico de Valencia, Valencia, Spain.

Ignacio Mosquera-Pérez (I)

Servicio de Cardiología, Complejo Hospitalario Canalejo, A Coruña, Spain.

Miguel Á Arias (MÁ)

Servicio de Cardiología, Hospital Universitario Virgen de la Salud, Toledo, Spain.

Ernesto Díaz-Infante (E)

Servicio de Cardiología, Hospital Universitario Virgen de la Macarena, Seville, Spain.

Víctor Expósito (V)

Servicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.

Víctor Jiménez-Ramos (V)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.

Elvis Teijeira (E)

Servicio de Cardiología, Hospital Universitario Vigo, Vigo, Pontevedra, Spain.

María Victoria Cañadas-Godoy (MV)

Servicio de Cardiología, Hospital Universitario Clínico de Madrid, Madrid, Spain.

José María Guerra-Ramos (JM)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario Sant Pau de Barcelona, Barcelona, Spain.

Teresa Oloriz (T)

Servicio de Cardiología, Hospital Universitario Clínico de Zaragoza, Zaragoza, Spain.

Nuria Basterra (N)

Servicio de Cardiología, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.

Pedro Sousa (P)

Departamento de Cardiología, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

Juliana Elices-Teja (J)

Servicio de Cardiología, Hospital Universitario Lucus Augusti, Lugo, Spain.

Ignacio García-Bolao (I)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.

José Ramón González-Juanatey (JR)

Servicio de Cardiología, Hospital Universitario Santiago de Compostela, Santiago de Compostela, A Coruña, Spain; Instituto de Investigación Sanitaria (IDIS), Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.

Ramón Brugada (R)

Centro de Genética Cardiovascular, Universidad of Girona, Girona, Spain.

Juan Ramón Gimeno (JR)

Servicio de Cardiología, Hospital Universitario de Murcia, Murcia, Spain.

Josep Brugada (J)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Sección de Arritmias, Servicio de Cardiología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain; The European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart - ERN GUARD-Heart.

Elena Arbelo (E)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Sección de Arritmias, Servicio de Cardiología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain; The European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart - ERN GUARD-Heart.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH